Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial

被引：0

作者：

Baraliakos, Xenofon ^{[1
]}

Gossec, Laure ^{[2
,3
]}

Pournara, Effie ^{[4
]}

Jeka, Slawomir ^{[5
]}

Blanco, Ricardo ^{[6
]}

D'Angelo, Salvatore ^{[7
]}

Schett, Georg ^{[8
]}

Schulz, Barbara ^{[4
]}

Rissler, Michael ^{[4
]}

Whyms, Dermot ^{[9
]}

Perella, Chiara ^{[4
]}

Coates, Laura ^{[10
]}

机构：

[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Bochum, Germany

[2] Sorbonne Univ, Paris, France

[3] Hop Univ Pitie Salpetriere, Paris, France

[4] Novartis Pharma AG, Basel, Switzerland

[5] CM UMK, Univ Hosp 2, Bydgoszcz, Poland

[6] Hosp Univ Marques Valdecilla, Santander, Cantabria, Spain

[7] San Carlo Hosp Potenza, Dept Rheumatol, Lucania & Rheumatol Inst Lucania IRel, Potenza, Italy

[8] Friedrich Alexander Univ Erlangen Nuremberg, Erlangen, Germany

[9] Novartis Ireland Ltd, Dublin, Ireland

[10] Univ Oxford, Oxford, England

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0505

引用

页数：3

共 50 条

[1] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS: RESULTS FROM THE MAXIMISE TRIAL
Baraliakos, Xenofon
Gossec, Laure
Pournara, Effie
Jeka, Slawomir
Blanco, Ricardo
D'Angelo, Salvatore
Schett, Georg
Schulz, Barbara
Rissler, Michael
Whyms, Dermot
Perella, Chiara
Coates, Laura C.
RHEUMATOLOGY, 2021, 60 : 98 - 98
[2] SECUKINUMAB IMPROVES CLINICAL AND IMAGING OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS AND AXIAL MANIFESTATIONS WITH INADEQUATE RESPONSE TO NSAIDS: WEEK 52 RESULTS FROM THE MAXIMISE TRIAL
Baraliakos, X.
Gossec, L.
Pournara, E.
Jeka, S.
Blanco, R.
D'angelo, S.
Schett, G.
Schulz, B.
Rissler, M.
Nagar, K.
Perella, C.
Coates, L. C.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 35 - 36
[3] Efficacy of secukinumab in managing axial manifestations and nail psoriasis in patients with psoriatic arthritis: Results from the MAXIMISE trial
Gottlieb, Alice B.
Baraliakos, Xenofon
Coates, Laura C.
Pournara, Effie
Rissler, Michael
Whyms, Dermot
Perella, Chiara
Reich, Kristian
Gladman, Dafna D.
Aassi, Maher
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB72 - AB72
[4] Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
Baraliakos, Xenofon
Gossec, Laure
Pournara, Effie
Jeka, Slawomir
Mera-Varela, Antonio
D'Angelo, Salvatore
Schulz, Barbara
Rissler, Michael
Nagar, Kriti
Perella, Chiara
Coates, Laura C.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (05) : 582 - 590
[5] SECUKINUMAB IMPROVES AXIAL MANIFESTATIONS IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NSAIDS: PRIMARY ANALYSIS OF THE MAXIMISE TRIAL
Baraliakos, Xenofon
Coates, Laura C.
Gossec, Laure
Jeka, Slawomir
Varela, Antonio Mera
Schulz, Barbara
Rissler, Michael
Das Gupta, Ayan
Perella, Chiara
Pournara, Effie
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 195 - 196
[6] Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
Baraliakos, Xenofon
Pournara, Effie
Gossec, Laure
Mease, Philip J.
White, Roisin
O'Brien, Eamonn
Schulz, Barbara
Marzo-Ortega, Helena
Coates, Laura C.
RMD OPEN, 2022, 8 (02):
[7] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 104 WEEKS RESULTS FROM A PHASE 3 TRIAL
McInnes, Iain B.
Mease, Philip
Ritchlin, Christopher T.
Rahman, Proton
Gottlieb, Alice B.
Kirkham, Bruce
RHEUMATOLOGY, 2017, 56 : 76 - 76
[8] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 104 Weeks Results from a Phase 3 Trial
McInnes, Kin B.
Mease, Philip J.
Ritchlin, Christopher T.
Rahman, Proton
Gottlieb, Alice B.
Kirkham, Bruce
Kajekar, Radhika
Delicha, Evie Maria
Pricop, Luminita
Mpofu, Shephard
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[9] Secukinumab Provides Early and Sustained Improvements in Health-Related Quality of Life in Patients with Psoriatic Arthritis: Pooled Results from the Secukinumab Phase 3 Trial Program
Strand, Vibeke
FitzGerald, Oliver
Coates, Laura C.
Walsh, Jessica
Canete, Juan A.
Nash, Peter
Davenport, Eric
Pricop, Luminita
Hustache, Gregory
Scheuer, Nicolas
Gilloteau, Isabelle
Augustin, Matthias
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[10] Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort
Tecer, Duygu
Yilmaz, Sedat
RHEUMATOLOGY, 2024, 63 (04) : e140 - e141

← 1 2 3 4 5 →